Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most frequently occurring cancers with poor prognosis, and novel diagnostic or prognostic biomarkers and therapeutic targets for HCC are urgently required. With the advance of high-resolution microarrays and massively parallel sequencing technology, lncRNAs are suggested to play critical roles in the tumorigenesis and development of human HCC. To date, dysregulation of many HCC-related lncRNAs such as HULC, HOTAIR, MALAT1, and H19 have been identified. From transcriptional “noise” to indispensable elements, lncRNAs may re-write the central dogma. Also, lncRNAs found in body fluids have demonstrated their utility as fluid-based noninvasive markers for clinical use and as therapeutic targets for HCC. Even though several lncRNAs have been characterized, the underlying mechanisms of their contribution to HCC remain unknown, and many important questions about lncRNAs need resolving. A better understanding of the molecular mechanism in HCC-related lncRNAs will provide a rationale for novel effective lncRNA-based targeted therapies. In this review, we highlight the emerging roles of lncRNAs in HCC, and discuss their potential clinical applications as biomarkers for the diagnosis, prognosis, monitoring and treatment of HCC.

[1]  Fang Wang,et al.  Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell‐like property of hepatocellular carcinoma cells by stabilizing NOP2 , 2014, Hepatology.

[2]  Z. Yin,et al.  The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma. , 2014, Journal of hepatology.

[3]  Masaharu Kataoka,et al.  Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease , 2014, Cells.

[4]  K. Nan,et al.  Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. , 2014, World journal of gastroenterology.

[5]  Juanjuan Zhu,et al.  The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis , 2014, PloS one.

[6]  Shuhan Sun,et al.  Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma. , 2014, Cancer letters.

[7]  J. Licht,et al.  Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer—Different Paths, Same Destination , 2014, Clinical Cancer Research.

[8]  G. Malaguarnera,et al.  Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies , 2014, BioMed research international.

[9]  Xing-Hua Li,et al.  Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. , 2014, International journal of clinical and experimental pathology.

[10]  T. Zhou,et al.  Long Non-coding RNA URHC Regulates Cell Proliferation and Apoptosis via ZAK through the ERK/MAPK Signaling Pathway in Hepatocellular Carcinoma , 2014, International journal of biological sciences.

[11]  Tushar Patel,et al.  Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy , 2014, Molecular Cancer Research.

[12]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[13]  T. Patel,et al.  Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer , 2014, FEBS open bio.

[14]  A. Mohamadkhani,et al.  Long Noncoding RNAs in Interaction With RNA Binding Proteins in Hepatocellular Carcinoma , 2014, Hepatitis monthly.

[15]  Xiaoshan Feng,et al.  Microarray Expression Profile Analysis of Long Non-Coding RNAs in Human Gastric Cardiac Adenocarcinoma , 2014, Cellular Physiology and Biochemistry.

[16]  Tushar Patel,et al.  Modulation of hypoxia-signaling pathways by extracellular linc-RoR , 2014, Journal of Cell Science.

[17]  Christian Ruiz,et al.  Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients , 2014, Hepatology.

[18]  Cheng Huang,et al.  Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. , 2014, Cancer letters.

[19]  J.-L. Huang,et al.  Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. , 2014, Carcinogenesis.

[20]  I. Rusyn,et al.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. , 2014, Cancer letters.

[21]  Baohong Zhang,et al.  Expression of microRNAs and their targets regulates floral development in tobacco (Nicotiana tabacum) , 2014, Functional & Integrative Genomics.

[22]  Xiang-Qi Wu,et al.  Compared Analysis of LncRNA Expression Profiling in pdk1 Gene Knockout Mice at Two Time Points , 2013, Cellular Physiology and Biochemistry.

[23]  Yan He,et al.  A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma. , 2013, DNA and cell biology.

[24]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[25]  Shuhan Sun,et al.  H19 inhibits RNA polymerase II-mediated transcription by disrupting the hnRNP U-actin complex. , 2013, Biochimica et biophysica acta.

[26]  Zhiying Ai,et al.  AICAR Sustains J1 Mouse Embryonic Stem Cell Self-Renewal and Pluripotency by Regulating Transcription Factor and Epigenetic Modulator Expression , 2013, Cellular Physiology and Biochemistry.

[27]  Yangchao Chen,et al.  Targeting long non-coding RNAs in cancers: progress and prospects. , 2013, The international journal of biochemistry & cell biology.

[28]  E. Lander,et al.  The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread Across the X Chromosome , 2013, Science.

[29]  Wen-Lang Lin,et al.  Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. , 2013, Genes & cancer.

[30]  Y. Nie,et al.  Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. , 2013, Biochemical pharmacology.

[31]  Hongwei Ma,et al.  Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma , 2013, BioMed research international.

[32]  Yue Wang,et al.  Hepatitis B virus X protein (HBx)‐related long noncoding RNA (lncRNA) down‐regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin , 2013, Hepatology.

[33]  Xinying Li,et al.  The role of noncoding RNA in hepatocellular carcinoma. , 2013, Gland surgery.

[34]  G. Wakabayashi,et al.  Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. , 2013, Oncology reports.

[35]  Shuhan Sun,et al.  Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. , 2013, Carcinogenesis.

[36]  Rong Yin,et al.  Long noncoding RNA: an emerging paradigm of cancer research , 2013, Tumor Biology.

[37]  Long Yu,et al.  An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. , 2012, Cancer research.

[38]  Shuhan Sun,et al.  Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence‐free survival after hepatectomy , 2012, Hepatology.

[39]  T. Krech,et al.  Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma , 2012, PloS one.

[40]  F. Zhang,et al.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation , 2012, Medical Oncology.

[41]  Deeksha Bhartiya,et al.  Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions , 2012, PloS one.

[42]  Yumei Du,et al.  Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18* , 2012, The Journal of Biological Chemistry.

[43]  M. Kyba,et al.  The H19 lincRNA is a developmental reservoir of miR-675 which suppresses growth and Igf1r , 2012, Nature Cell Biology.

[44]  Juan Wen,et al.  A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population , 2012, PloS one.

[45]  Q. Li,et al.  Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression , 2011, The Journal of international medical research.

[46]  C. Croce,et al.  microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer , 2011, Oncogene.

[47]  Shuhan Sun,et al.  Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans , 2011, Hepatology.

[48]  Howard Y. Chang,et al.  Understanding the transcriptome through RNA structure , 2011, Nature Reviews Genetics.

[49]  Thomas D. Schmittgen,et al.  microRNA Replacement Therapy for Cancer , 2011, Pharmaceutical Research.

[50]  Haiyang Xie,et al.  Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation , 2011, Annals of Surgical Oncology.

[51]  B. Blencowe,et al.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.

[52]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[53]  Jiayi Wang,et al.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.

[54]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[55]  Jiajia Wang,et al.  Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. , 2010, Acta biochimica et biophysica Sinica.

[56]  Christopher W. J. Smith,et al.  Alternative splicing: global insights , 2010, The FEBS journal.

[57]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[58]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[59]  Wenhan He,et al.  Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. , 2008, Genomics.

[60]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[61]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[62]  M. Karin,et al.  A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas , 2007, Oncogene.

[63]  Wensheng Yan,et al.  RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. , 2006, Genes & development.

[64]  H. Blum,et al.  Hepatocellular carcinoma: therapy and prevention. , 2005, World journal of gastroenterology.

[65]  U. Moens,et al.  The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. , 2005, Cellular signalling.

[66]  N. Iizuka,et al.  Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. , 2004, Anticancer research.

[67]  T. Sohda,et al.  In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma , 1998, Journal of Human Genetics.

[68]  Y. I. Lee,et al.  Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. , 1997, Cancer letters.

[69]  C. Trautwein,et al.  Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. , 1997, Cancer research.

[70]  Hiromu Suzuki,et al.  Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. , 1996, Oncogene.

[71]  Xiaoming Fan,et al.  Long non-coding RNAs and hepatocellular carcinoma. , 2015, Molecular and clinical oncology.

[72]  Q. Wang,et al.  Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[73]  Xiao‐hui Huang,et al.  Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway , 2014, Journal of Huazhong University of Science and Technology [Medical Sciences].

[74]  A. Hochberg,et al.  Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. , 2012, International journal of clinical and experimental medicine.

[75]  Vinod Scaria,et al.  © 2012 Landes Bioscience. Do not distribute. Potential G-quadruplexes in the human long non-coding transcriptome , 2012 .

[76]  J. Cáceres,et al.  The SR protein family of splicing factors: master regulators of gene expression. , 2009, The Biochemical journal.

[77]  K. Zatloukal,et al.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. , 2007, Gastroenterology.

[78]  Wenhan He,et al.  [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma]. , 2007, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[79]  Xiang-Dong Fu,et al.  SR proteins and related factors in alternative splicing. , 2007, Advances in experimental medicine and biology.